TrialHemodialysis international. International Symposium on Home Hemodialysis2026

Safety and Efficacy of Vadadustat Versus Darbepoetin Alfa for Chronic Kidney Disease-Related Anemia in Patients Receiving Dialysis by Baseline Erythropoiesis-Stimulating Agent Dose.

Alan Jardine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.